Women address chronic UTIs on social media, demand better healthcare responses

Adrianne, a 29‑year‑old digital marketer in London, told roughly 8,000 TikTok followers that she has been living with a chronic urinary tract infection for almost five years, a condition that took two years to be diagnosed after she was repeatedly misdiagnosed with colon cancer, Crohn’s disease and even a sexually transmitted infection.

Her story reflects a growing wave of women speaking out about recurrent UTIs, a problem that experts say may affect up to 1.7 million women in the UK, as well as men and children. Social media platforms now host hundreds of posts where women share symptoms, coping tips and the emotional toll of the illness. Adrianne said she was nervous to go public, but the online community has given her a sense of solidarity and practical advice that she could not find in clinics.

Chronic UTIs are not formally defined in medicine, but they involve persistent pain, urgency and frequent urination even after a standard antibiotic course. Adrianne describes excruciating abdominal spasms and a feeling of “wee‑ing lava,” leaving her unable to work, socialize or maintain relationships. Doctors often rely on urine samples, yet false‑negative results are common, according to Professor Chris Harding, a urologist at Newcastle upon Tyne Hospitals. He warns that the infection can hide behind other conditions such as painful bladder syndrome, chronic pelvic pain and endometriosis, which complicates diagnosis. Magda Kujawa, a consultant urologist at Stockport NHS Foundation Trust, stresses that clinicians must listen to patients’ histories to distinguish chronic infection from overlapping disorders.

The growing visibility of chronic UTIs on social media is prompting calls for better diagnostic pathways and more empathetic care. Health professionals are urged to move beyond generic advice about hydration and hygiene and to consider persistent symptoms as a possible chronic infection. As more women like Adrianne share their experiences, the pressure builds for research funding, clearer clinical guidelines and a reduction in the stigma that has long silenced sufferers.